Tirzepatide 15mg High-Puriy Research Peptide

Tirzepatide 15mg High-Puriy Research Peptide Product Overview Tirzepatide 15 mg is a high-purity research -grade dual incretin peptide designed for laboratory and scientific research applications. Frequently cited in peer-reviewed literature for its interaction with both GIP and GLP-1 receptor pathways , this concentration is well suited for precision studies, pilot research, and comparative metabolic investigations. Supplied strictly for research use only (RUO) . Key Features 15 mg precision research vial Dual GIP & GLP-1 receptor research focus Lyophilized powder for enhanced stability Ideal for early-phase and controlled research protocols Batch-tested for purity and consistency Research Uses Tirzepatide is commonly referenced in laboratory research involving: Dual incretin receptor signaling studies Metabolic and endocrine pathway analysis Glucose regulation and insulin signaling models Energy balance and appetite-related research ⚠️ Disclaimer: This product is intended exclusively for laboratory research purposes. Not approved for human or veterinary use. Product Specifications Product Name: Tirzepatide Strength: 15 mg Form: Lyophilized powder Grade: Research Use Only (RUO) Storage: Store in a cool, dry environment; refrigerate after reconstitution according to laboratory standards USA Shipping & Availability Fast and reliable USA domestic shipping Secure, professional laboratory-grade packaging Available to qualified research laboratories and institutions across the United States Advantages and Disadvantages Advantages Ideal concentration for precision and pilot research studies Supports advanced dual GIP and GLP-1 pathway investigations High purity and consistency trusted by USA researchers Disadvantages Not approved for clinical, diagnostic, or therapeutic use Requires proper laboratory handling and controlled storage Frequently Asked Questions (FAQs) Q: Is Tirzepatide 15 mg FDA-approved for medical use? A: No. This product is sold strictly for research purposes only. Q: Who can purchase Tirzepatide 15 mg? A: Qualified laboratories, researchers, and research institutions. Q: Do you ship Tirzepatide 15 mg within the USA? A: Yes, this product ships domestically within the United States.

---

Expanded Research Background & Molecular Mechanisms

Structural Identity & Pharmacological Classification

TIRZEPATIDE (Dual GIP/GLP-1 Receptor Agonist) is supplied as a 15 mg research-grade lyophilized powder for controlled laboratory investigation. CAS: 2023788-19-2. The molecular architecture — H-Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys-Ile-Ala-Gln-Lys(AEEA-AEEA-γ-Glu-eicosanedioic acid)-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 — confers specific structural features that determine receptor binding kinetics, metabolic stability, and biological activity profiles relevant to preclinical research applications. Each batch is synthesized under strictly controlled solid-phase peptide synthesis (SPPS) conditions using Fmoc chemistry, purified via preparative reverse-phase HPLC, and verified through comprehensive analytical characterization including high-resolution mass spectrometry and amino acid analysis.

Primary Mechanism of Action

The biological activity of TIRZEPATIDE is mediated through high-affinity interaction with its cognate receptor(s). Upon receptor engagement, conformational changes in the receptor-ligand complex trigger intracellular signaling cascades involving G-protein coupling, second messenger generation (cAMP, IP3, Ca²⁺), and downstream kinase activation. These signaling events culminate in transcriptional reprogramming of target genes through activation of transcription factors including CREB, NF-κB, and AP-1, depending on the specific receptor system and cell type under investigation. The concentration-response relationship typically follows classical sigmoidal kinetics with EC₅₀ values in the nanomolar to micromolar range, making TIRZEPATIDE suitable for dose-response experimental designs across multiple biological replicate conditions.

Downstream Signaling & Cellular Responses

Research investigations have elucidated several key downstream pathways activated by TIRZEPATIDE:

1. MAPK/ERK Cascade: Receptor activation → Ras → Raf → MEK → ERK1/2 phosphorylation → nuclear translocation → transcription of immediate-early genes (c-Fos, c-Jun, Egr-1) → cellular proliferation and differentiation responses. This pathway is particularly relevant in tissue remodeling, wound healing, and regenerative biology research contexts.

2. PI3K/Akt/mTOR Axis: Parallel signaling through PI3K → PIP₃ → PDK1 → Akt phosphorylation (Thr308, Ser473) → mTORC1 activation → enhanced protein translation via 4E-BP1 and S6K1 phosphorylation. This pathway supports anabolic signaling, cell survival, and metabolic reprogramming studies.

3. JAK/STAT Pathway: In cytokine-responsive systems, TIRZEPATIDE-mediated receptor dimerization recruits JAK kinases → STAT protein phosphorylation → STAT dimerization → nuclear translocation → target gene transcription. This pathway is central to immunomodulation and hematopoietic research.

4. Calcium Mobilization: Gαq-coupled signaling → PLCβ activation → IP₃-mediated Ca²⁺ release from ER stores → calmodulin-dependent kinase (CaMK) activation → diverse cellular responses including secretion, contraction, and gene expression.

Pharmacokinetic Considerations for Research Design

For laboratory research applications, several pharmacokinetic parameters inform experimental design:

• Reconstitution: Lyophilized TIRZEPATIDE should be reconstituted in sterile, preservative-free aqueous buffer (PBS pH 7.4 or sterile water) to the desired stock concentration. Gentle swirling — not vortexing — is recommended to prevent peptide aggregation and ensure complete dissolution.
• Stability: Reconstituted solutions maintain full biological activity for up to 30 days when stored at 2–8°C, protected from light. For extended storage, aliquot into single-use volumes and store at -20°C or -80°C. Avoid repeated freeze-thaw cycles, which can cause 3–8% activity loss per cycle due to peptide aggregation and potential oxidation of sensitive residues.
• Working Concentrations: Typical in vitro working concentrations range from 1 nM to 100 μM, depending on the assay system and experimental endpoint. Preliminary dose-ranging experiments (logarithmic dilution series: 0.1, 1, 10, 100, 1000 nM and 1, 10, 100 μM) are recommended to establish the optimal concentration range for each specific research application.

Comparative Pharmacology & Research Context

TIRZEPATIDE occupies a distinct position within the broader peptide research landscape. Compared to structurally related compounds, TIRZEPATIDE exhibits unique receptor selectivity profiles, signaling bias characteristics (G-protein vs. β-arrestin coupling), and pharmacokinetic properties that make it a valuable tool for dissecting specific biological pathways. Researchers should consider the following when designing comparative studies:

• Receptor Selectivity: Verify receptor specificity through competitive binding assays using pharmacologically relevant concentrations of selective antagonists.
• Signaling Bias: Quantify both G-protein-mediated (cAMP, IP₁ accumulation) and β-arrestin-mediated (receptor internalization, ERK phosphorylation) signaling to fully characterize functional selectivity.
• Batch Consistency: For multi-phase research programs spanning extended time periods, procure peptide from the same manufacturing batch to eliminate batch-to-batch variability as a confounding factor.

Quality Control Verification Protocol

Before initiating experimental procedures, researchers should verify:

1. Peptide identity by mass spectrometry (observed MW within ±1.0 Da of theoretical)
2. Purity ≥98% by analytical HPLC at 214 nm
3. Peptide content ≥80% by quantitative amino acid analysis
4. Endotoxin levels ≤1.0 EU/mg (critical for cell-based assays)
5. Visual inspection: white to off-white lyophilized powder with no discoloration or clumping

These verification steps ensure experimental reproducibility and data integrity across research programs.

Related Research & Resources

Resource	Description
Glp 1 Metabolic Peptides Hub	Complete research overview & methodology hub
High Purity Tirzepatide 50Mg	Related research peptide product
Tirzepatide 10 Mg Research Peptide Vials	Related research peptide product
Glp 1 Peptides Metabolic Research	Latest research insights & methodology

View Complete Research Guide »